Home| About us| Widget| login/register| For authors| For reviewers |Submit a paper
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


 Yes, sign up now
 Sign up for general news too

Privacy Statement
 
 
 

Clinical Medicine: Blood Disorders

Synopsis: An open access, peer reviewed electronic journal that covers the diagnosis, management and prevention of blood disorders.


Indexing: 6 major databases. Pubmed indexing for NIH-funded research.

Processing time: Decision in 2 weeks for 90% of papers.

Visibility: Most popular article read 700+ times.

View factor
for journal
20360


About this journal

ISSN: 1178-2269


Aims and scope:

Clinical Medicine: Blood Disorders is an international, open access, peer reviewed journal which considers manuscripts on all aspects of the diagnosis, management and prevention of blood disorders, in addition to related genetic, pathophysiological and epidemiological topics.

Editorial standards and procedures:

Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers.  Reviewers are required to provide fair, balanced and constructive reports.  

Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair.  Appeals are considered by the Editor in Chief or Associate Editor.

Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.

Indexing:

This journal is indexed by the following services:

  • Google Scholar
  • CAS
  • DOAJ
  • SCOPUS
  • Embase
  • OAIster

National Institutes of Health Public Access Policy compliant:

As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.

If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf. 



 
 
 


Birth MCV and MCH are Quite Reliable Parameters for the Prediction of Alpha Thalassemia Trait

Authors: Al-Hilali Akram, Abu Saud Khalida, Sofi Sawsan and La Cock Charles
Publication Date: 13 May 2009
Clinical Medicine: Blood Disorders 2009:2 1-4

Al-Hilali Akram*, Abu Saud Khalida, Sofi Sawsan and La Cock Charles

Pathology Department, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia, *Current address: Dubai Health Authority, Dubai, UAE.

Abstract

To assess some simple blood parameters at birth that can be used as a basis to suspect α-thalassemia minor (ATM), a prospective study involving 202 consecutive neonates with MCV of less than 95 fl or less were checked for Hb Barts by HPLC. The group was divided into two, one with an MCV of 90–95 (89 cases) and the other with an MCV below 90 (113 cases). For control, 104 consecutive neonates with an MCV 95 fl were similarly checked. It has been confirmed that an MCV that is below 90 fl, especially with and MCH of 30 pg is a strong indicator of the presence of ATM (109/113). On the other hand, MCV of 90 or more, especially with an MCH of 30 or more is a strong negative indicator for ATM (70/89). Firm diagnosis of ATM at birth can thus be secured in majority of neonates.

Categories: Blood disorders


Post comment




No comments yet...Be the first to comment.

Bookmark this article

LINKEDIN FACEBOOK

Add to Mixx! MIXX YAHOO! BUZZ

PERMALINK DIGG


Sign up for free journal updates

How should we address you?
Your email address
 Yes, sign up now




Related journals...